DCM
IMDZ

Driehaus Capital Management’s Immune Design Corp. IMDZ Stock Holding History

Driehaus Capital Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-140,720
Closed -$2.48M – 698
2014
Q3 		$2.48M Buy
+140,720
New +$1.78M 0.09% 276

Other funds holding IMDZ

CGL
Column Group LP San Francisco, California $38.6M AUM 30.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's IMDZ Position: Q4 2014 in Review

Driehaus Capital Management sold out of Immune Design Corp. (IMDZ) in Q4 2014, closing a stake of 140,720 shares — an estimated $2.48M sold.

Driehaus Capital Management first reported a position in IMDZ in Q3 2014 and held it in 1 quarter. The position peaked at $2.48M in Q3 2014. 41 funds tracked by Wall St. Rank hold IMDZ as of Q4 2014.

  • Driehaus Capital Management reported no remaining Immune Design Corp. position as of Q4 2014 after selling out during the quarter.
  • Driehaus Capital Management sold 140,720 Immune Design Corp. shares in Q4 2014, an estimated $2.48M.
  • Driehaus Capital Management first reported a position in Immune Design Corp. in Q3 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Immune Design Corp. position peaked at $2.48M in Q3 2014.
  • 41 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2014.

Based on Driehaus Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.